Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTt Electronics Regulatory News (TTG)

Share Price Information for Tt Electronics (TTG)

Share Price is delayed by 15 minutes
Get Live Data
116.40    0.80 (0.69%)
Bid:
116.20
Ask:
116.40
Spread: 0.20 (0.172%)
Market Cap: £207.63m
TTG Live PriceLast checked at - London Stock Exchange

Intraday Tt Electronics Share Chart

Trading Statement

17 Nov 2016 07:00

RNS Number : 3946P
TT Electronics PLC
17 November 2016
 

 

17 November 2016

 

TT Electronics plc

 

Trading Update

 

 

TT Electronics ("TT" or the "Group"), a global provider of engineered electronics for performance critical applications, today publishes this trading update for the period to the end of October 2016.

 

 

Overall, the Group continues to perform well. As expected, the Group's revenues have grown on an organic1 basis in the four months to the end of October 2016.

 

The Group's order book is marginally ahead of the prior year, before the additional contribution from Aero Stanrew where the order intake continues to be encouraging. Notably, we have secured the first contract win as a result of the integration of Aero Stanrew and TT.

 

Trading results have continued to be favourably impacted by exchange rate movements to date, increasing revenue and underlying operating profit in the first 10 months of the year by approximately £30m and £2.5m respectively.

 

The cash generation of the business remains on track to see an improved performance in the second half of the year. In addition, the former head office site in Weybridge was sold in September generating net cash proceeds of circa £6m.

 

Summary and Outlook

 

Commenting on the trading statement, Richard Tyson, Chief Executive Officer said:

 

"We are pleased with our year to date performance, having grown organic revenues in the four months since the half year against a challenging backdrop in some of our markets. Our strategy to position ourselves in structural growth markets where there is increasing electronic content continues to gain traction. Our strong business performance is in line with our plans and is being enhanced by benefits from favourable exchange rates, and we therefore expect to be ahead of market expectations for the year as a whole."

 

 

On Tuesday 22 November, we will be holding an investor event focused on our power electronic capabilities in Aerospace and Defence, a component of TT fuelling growth for the future. The presentation materials will be available on the IR section of our website following the event.

 

For further information please contact:

TT Electronics plc

Tel: +44 (0)1932 825 300

Richard Tyson, Chief Executive Officer

Mark Hoad, Chief Financial Officer

Emma Darke, Head of Investor Relations and Communications

MHP

Tel: +44 (0)20 3128 8100

Tim Rowntree / Jamie Ricketts

1

Notes:

 

1 Excluding the impact of exchange rates, acquisitions and disposals.

Cautionary statement

This trading update contains forward-looking statements. These have been made by the directors in good faith based on the information available to them up to the time of their approval of this update. The directors can give no assurance that these expectations will prove to have been correct. Due to the inherent uncertainties, including both economic and business risk factors underlying such forward looking information, actual results may differ materially from those expressed or implied by these forward-looking statements. The directors undertake no obligation to update any forward-looking statements whether as a result of new information, future events or otherwise.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDQLFFQFFEFBX
Date   Source Headline
28th Apr 20226:05 pmRNSDirector/PDMR Shareholding
27th Apr 20225:20 pmRNSDirector/PDMR Shareholding
27th Apr 202211:22 amRNSHolding(s) in Company
6th Apr 20224:15 pmRNSAnnual Financial Report
17th Mar 20227:00 amRNSDirector/PDMR Shareholding
16th Mar 20224:16 pmRNSDirector/PDMR Shareholding
15th Mar 202211:29 amRNSDirector Declaration
14th Mar 20223:00 pmRNSDirector/PDMR Shareholding
14th Mar 20223:00 pmRNSDirector/PDMR Shareholding
9th Mar 20227:00 amRNSFull Year Results
1st Mar 20223:35 pmRNSTotal Voting Rights
2nd Feb 20224:30 pmRNSHolding(s) in Company
1st Feb 20223:05 pmRNSTotal Voting Rights
10th Jan 20227:00 amRNSAcquisition of Ferranti Power & Control business
4th Jan 20222:20 pmRNSTotal Voting Rights
22nd Dec 202110:07 amRNSHolding(s) in Company
15th Dec 20214:00 pmRNSHolding(s) in Company
1st Dec 20213:06 pmRNSTotal Voting Rights
23rd Nov 20217:00 amRNSTrading Update
1st Nov 20215:05 pmRNSBlock Listing Six Monthly Return
1st Nov 20214:56 pmRNSDirector/PDMR Shareholding
30th Sep 20219:40 amRNSDirector/PDMR Shareholding
1st Sep 20211:30 pmRNSTotal Voting Rights
5th Aug 20217:00 amRNSHalf-year Results
2nd Aug 20213:38 pmRNSTotal Voting Rights
2nd Jul 20215:10 pmRNSTotal Voting Rights
16th Jun 20211:32 pmRNSUpdate on 2021 LTIP Award Targets
14th Jun 202110:16 amRNSHolding(s) in Company
1st Jun 20218:11 amRNSTotal Voting Rights
13th May 20211:19 pmRNSResult of AGM
13th May 20217:00 amRNSAGM Trading Update
12th May 20214:39 pmRNSDirector/PDMR Shareholding
4th May 20213:00 pmRNSBlock listing Interim Review
4th May 202110:42 amRNSTotal Voting Rights
1st Apr 20214:22 pmRNSTotal Voting Rights
1st Apr 202111:23 amRNSAnnual Report and AGM Arrangements
29th Mar 20218:05 amRNSHolding(s) in Company
26th Mar 20217:00 amRNSVirolens® registration received in Great Britain
25th Mar 202112:11 pmRNSUpdate on Virolens
19th Mar 202112:11 pmRNSDirector/PDMR Shareholding
18th Mar 20213:18 pmRNSHolding(s) in Company
16th Mar 20213:50 pmRNSDirector/PDMR Shareholding
16th Mar 20213:49 pmRNSDirector/PDMR Shareholding
10th Mar 202112:40 pmRNSHolding(s) in Company
10th Mar 20217:00 amRNSFull Year Results
1st Mar 202112:30 pmRNSTotal Voting Rights
8th Feb 20216:20 pmRNSHolding(s) in Company
1st Feb 202111:36 amRNSTotal Voting Rights
20th Jan 20214:55 pmRNSHolding(s) in Company
19th Jan 20213:45 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.